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Abstrak 
 
Malaria merupakan masalah kesehatan utama di propinsi Papua. Meluasnya penyebaran parasit malaria dan penanganan program 
malaria yang tidak teratur serta diikuti adanya krisis ekonomi dan perselisihan di masyarakat Papua pada akhir tahun 1990an telah 
mengakibatkan situasi malaria di daerah Papua semakin terpuruk. Untuk menentukan besaran permasalahan malaria saat ini, suatu survei 
malariometrik telah dilakukan di tiga Kecamatan di Kabupaten Jayapura serta uji sensitifitas obat antimalaria sulfadoksin-pirimetamin (SP) 
pada pasien malaria di unit rawat jalan RSU Abepura, Puskesmas Hamadi dan Poliklinik Panti Asuhan Katolik Sentani, Kabupaten Jayapura, 
Propinsi Papua. Pada survei malariometrik, dari 543 subyek yang diperiksa, ditemukan 185 subyek terinfeksi malaria P.falciparum, dan P.vivax 
serta infeksi campuran keduanya. Seluruh kasus malaria yang ditemukan merupakan kasus tanpa gejala (asimtomatik). Pada uji sensitifitas 
obat antimalaria dengan SP, dari 56 subyek yang diikutsertakan, ditemukan 32 subyek mengalami kegagalan pengobatan dini (KPD) dan 2 
subyek mengalami kegagalan pengobatan kasep (KPK) serta 22 subyek berhasil pada pengobatan ini. Hasil-hasil di atas menunjukkan 
bahwa prevalensi malaria di Kabupaten Jayapura serta angka kegagalan pengobatan SP cukup tinggi dan oleh karena itu diperlukan adanya 
obat antimalaria baru yang sesuai dengan keadaan pada daerah tersebut. (Med J Indones 2007; 16:32-8)    
 
 
Abstract  
 
Malaria poses a major public health problem in Papua.  The rapid spread of drug-resistant parasites and deterioration of the malaria 
control program following the monetary crisis and civil strife in the late 90’es have worsened the malaria situation in many areas of 
Papua. To re-assess the current magnitude of malaria problem, a malariometric survey was conducted in three sub-districts of Jayapura District, 
as well as antimalarial drug sensitivity test using sulfadoxine-pyrimethamine (SP) at the outpatient clinics of Abepura General Hospital 
(RSU), Hamadi Primary Health Center and Panti Asuhan Katolik Clinics, Sentani, Jayapura District, Papua Province. Screening of 543 
subjects in three sub-districts revealed 185 malaria positive subjects, either with P. falciparum, P. vivax or mixed of the two species. All of the 
malaria cases were asymptomatic. In the SP drug sensitivity test, of the 56 subjects involved, 32 were classified as early treatment failure and two 
subjects were classified as late treatment failure. The remaining 22 subjects were classified as adequate clinical and parasitological 
response (ACPR). These results indicated that the surveyed area has a high malaria prevalence and treatment failure to SP and 
therefore alert to the need of deploying new antimalarial regiment that suit the remote setting. (Med J Indones 2007; 16:32-8)    
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Malaria represents a major public health problem in 
Indonesia especially in eastern islands, including 
Papua province.  In the year 2001, It was found that 
approx. 15 millions people were contracted with malaria, 
and thirty thousands death were reported. Studies 
performed within the last few years in various localities 
in Papua documented the malaria prevalence ranged 
from meso-to holoendemic status in the northeastern 
coast and highland parts of the province.
1,2
 This 
persistently high incidence of malaria in the area 
within the last few years was mainly attributed to the 
rapid spread of parasite resistance to the first and 
second line antimalarial drugs, chloroquine and 
sulfadoxine-pyrimethamine, and the lack of sustainable 
malaria control program.
3-5
 Resistance to chloroquine in 
Indonesia was first documented in Papua in 1975
6, 7
 
and current studies reported that this drug may no 
longer be effective in most areas of Papua.
4
 Resistance 
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to the second line antimalarial drug, sulfadoxine-
pyrimethamine, was also first reported in Papua in 1985
8
 
and continued to spread throughout the archipelago 
afterward.    
 
The malaria treatment in this area follows the guidelines 
set by the Ministry of Health,
5
 whereby chloroquine 
(25 mg base/kg body weight in three doses over 72-hour 
period), followed by 15 mg primaquine base per day 
for two weeks for P. vivax or a single 45 mg dose for 
P. falciparum, was used as first line therapy. The 
sulfadoxine-pyrimethamine combination is usually 
used as a second line therapy. The continued use of 
the two antimalarial drugs in this area despite its 
growing resistance status was associated with the lack 
of therapeutic options in the setting of a frontier area, 
where most treatment were given without proper 
monitoring and merely based on clinical symptom 
only. The aim of the present study was to determine 
the magnitude of the malaria problem in Jayapura 
district as well as the extent of the parasite resistance to 
antimalarial drug, sulfadoxine-pyrimethamine. Here we 
report the prevalence of malaria and the rate of 
treatment failure associated with the sulfadoxine-
pyrimethamine treatment in the area. 
METHODS 
 
Description of Study sites. The location of the Jayapura 
District within the Papua Province of Indonesia is 
shown in Figure 1. Jayapura District is located in the 
northeastern part of Papua Province, has an area of 
17,514 km2 and population of approx. 110,786.
9
 The 
district is bordered in the north by Pacific Ocean, in 
the south by Jayawijaya district, in the west with 
Yawa and Paniai district, and in the east with the Papua 
New Guinea. The Jayapura district is administratively 
divided into 24 sub-districts. The district is geographically 
consisting of marshy land and highland and rivers. 
The climate is typically tropical with average 
temperature between 25-35
o
C. The dry and wet seasons 
is not distinctly separated, with drier season between 
May to November and the monsoon between December 
to April. The average population of each village was 
approx. 2,000 people. The population consisted mainly 
of Papuan ethnic group, migrants from Java and 
Sulawesi. The majority of the population work as 
farmer or fisherman.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A sketch map of the Jayapura District (lined area), Jayapura City (white circle) and its geographic location within the Indonesia 
archipelago (inset).   
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Sample collection. A malariometric survey was 
conducted during 18-28 January 2005 in two selected 
villages in each of the three sub-districts, Jayapura 
Utara, Depapre and Sentani. The selected villages 
represented the coastal and inland environmental setting 
of malaria. The target population was the village 
inhabitants who joined voluntarily, and the blood will 
be taken through finger prick and prepared for thick 
and thin blood smear or blots on filter paper (3MM; 
Whatman, Hillsboro, OR). During the survey, basic 
7-day morbidity history including axial temperature, 
antimalarial drug use and drug allergy were checked. 
This study was carried out with the approval by the 
Ethics Committees at the Faculty of Medicine, University 
of Indonesia, Jakarta, Indonesia. 
 
Parasite detection. Thick and thin blood smears 
taken during the malariometric survey were stained 
with Giemsa, and subsequently examined by light 
microscopy. Parasite density was determined by counting 
the number of parasites per leukocytes in 100-high-
power microscopic fields in a Giemsa-stained thick 
film, assuming an average of 20 leukocytes per 
microscopic field and 8000 leukocytes/µl of blood. 
Slides were declared negative if parasite could not be 
detected in 100 microscopic fields. The parasite count 
was classified as: (+) if 1-10 parasites were found per 
100 thick film fields, (++) if 11-100 parasite per 100 
microscopic thick film fields, (+++) if 1-10 parasite 
per one thick film fields and (++++) if more than 10 
parasites per one thick film fields.
10
   
 
Antimalarial drug sensitivity test. The antimalarial 
drug sensitivity test with sulfadoxine-pyrimethamine 
was conducted during 9 July-28 September 2005 by 
recruiting malaria infected individuals in the outpatient 
clinics of RSU Abepura, Puskesmas Hamadi and 
Poliklinik Panti Asuhan Katolik Sentani, Jayapura 
District, Papua Province. The criteria for patients’ 
inclusion in the test include: age between 1-65 year 
old, patients do not have any symptom and sign of 
cerebral complication, mono infection with falciparum, 
parasite density of > 1000 parasite/µl blood, and signed 
the informed consent.
11
 A standard SP regiment was 
given to the subject based on the bodyweight and age 
under the observation of a nurse, and following the 
guidelines recommended by the Ministry of Health. 
 
 
RESULTS 
 
Malariometric surveys 
 
Among the 543 subjects involved in the survey in 5 
villages, of Jayapura Utara, Depapre and Sentani sub-
districts, 185 (34.1%) subjects were found to be 
positive for malaria, consisting 120 (22.1%) subjects 
carried P. falciparum, 58 (10.7%) subjects carried P. 
vivax and 7 (1.3%) subjects carried both P. falciparum 
and P. vivax (Table 1). The highest slide positivity 
rate was found in Tablasupa village of Depapre 
subdistrict.  Except in Sentani villages, P. falciparum 
was found to be the dominant species.   
 
 
 
Table 1. Malaria prevalence in Jayapura District 
 
District Village Malaria 
Cases 
Species ∑ 
Positive Pf Pv Pf+Pv 
Jayapura Utara 
Hamadi Pantai 148 40 (27*) 6 (4.05) 2 (1.35) 45 (30.4) 
Hamadi Lembah 89 8 (9) 4 (4.5) 1 (1.1) 12 (13.5) 
Depapre 
Depapre,  
Tablasupa I dan II 96 43 (45) 17 (17.7) 2 (2.1) 57 (59.4) 
Sentani 
Danau Sentani 65 10 (15.4) 25 (38.5) 1 (1.5) 36 (55.4) 
Sereh Atas 145 19 (13.1) 6 (4.1) 1 (0.7) 25 (17.2) 
Total  543 120 (22.1) 58 (10.7) 7 (1.3) 185 (34.1) 
 
(*) Number in bracket indicates percentage, Pf= Plasmodium falciparum,  Pv= Plasmodium vivax 
 
Based on the age group, the majority of the falciparum 
and vivax malaria cases occurred at younger age 
(Table 2). Falciparum malaria cases where slightly 
higher in men, whereas vivax cases were found to be 
almost doubled in women. Subjects that carried mixed 
infection was also predominantly found in men and at 
younger age. 
 
The parasite density and the presence of malaria 
symptom such as fever, chill, headache in malaria 
cases and nausea is shown in Table 3. Based on the 
parasitic density, the majority of the cases (82.7%) 
carried low parasitemia whereas the remaining carried 
mild and high parasitemia (Table 3). Twenty nine of 
the malaria cases, 21 falciparum malaria and 8 vivax 
malaria, were found to have symptom ranging from 
fever, chill, headache and nausea. The majority of the 
subjects that carry malaria symptom in falciparum 
malaria, was from the group that harbor low 
parasitemia whereas in vivax malaria, the subjects 
having malaria symptom are found in all parasite 
density levels. In falciparum malaria cases, the 
proportion of cases carrying gametocyte is also 
relatively high (43.3%, data not shown).    
 
Antimalarial drug sensitivity test 
At the outpatient’s clinics, a total 100 symptomatic 
falciparum malaria cases were found. The clinical 
manifestation among the subjects varied greatly from 
mild fever, anemia, splenomegaly, chill, head ache, 
nausea, lost of conscience and coma. Majority of the 
cases were from the age group of over 20 years old, 
and the remaining were from age group of 10-20 and 
less than 10. Of these, only 56 cases met the criteria to 
be involved in the antimalarial drug sensitivity test 
using sulfadoxine-pyrimethamine. The remaining 44 
cases were classified as severe malaria and received 
standard antimalarial drug treatment in the hospital. 
Of the 56 subjects that were involved in the drug test, 
32 cases exhibited no significant reduction in parasitemia 
at days 3 and therefore were classified as early 
treatment failures. Two other subjects were found to 
be positive at days 14 and classified as late treatment 
failure. The remaining 22 subjects were found to 
recover completely and were classified as adequate 
clinical and parasitological response (ACPR) (Table 4).   
 
 
Table 2.   Malaria prevalence by age group, sex and species in Jayapura District  
 
Age 
(year) 
Malaria Cases 
Total 
Pf Pv  Pf + Pv 
M F  M F M F 
0 < - 10 31 (37*) 21 (25) 15 (18) 14 (16) 3 (3) 1 (1) 85 
10 – 20 14 (22.2) 21 (33.3) 9 (14.3) !7 (27) 2 (3.2) 0 63 
> 20 12 (32) 11 (30) 0 14 (38) 0 0 37 
Total 57 53 24 45 5 1 185 
 
(*) Number in bracket indicates percentage, Pf:Plasmodium falciparum,  
Pv: Plasmodium vivax;  M, Male; F, Female 
 
 
Table 3. Parasite density and the presence of malaria symptom among malaria cases in Jayapura District 
   
Parasite density  
(per L) 
Pf Pv   Pf + Pv  Total Malaria Symptom 
    Pf Pv 
40 -400   (+1) 100 (65.3*) 47 (20.7) 6 (4) 153 19 3 
401-4000 (+2) 9 (52.9) 8 (47.1) 0 17 1 1 
4001-39.999 (+3) 4 (57.1) 3 (42.9) 0 7 0 3 
≥ 40.000 (+4) 7 (87.5) 1 (12.5) 0 8 1 1 
Total 120 59 6 185 21 8 
 
(*) Number in bracket indicates percentage, Pf:Plasmodium falciparum, Pv: Plasmodium vivax;  M, Male; F, Female 
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Table 4. Treatment monitoring and outcome of the subjects enrolled in in-vivo drug sensitivity test in Abepura General Hospital,  
Hamadi Primary Health Centre, and Panti Asuhan Katolik Clinics, Sentani, Jayapura District, Papua Province. 
 
Sample 
Code 
Parasitemia Results 
H0 H2 H3 H7 H14 H21 H28 ETF LTF ACPR 
1-KPA + + − − − − −   1 
2-KPA + + − − + − −  1  
3-KPA + + + + + - - 1   
4-KPA + + + + + - - 1   
5-KPA + + + + + + - 1   
6-KPA + - - + + - -  1  
7-KPA + + + + - - - 1   
8-KPA + + + + - - - 1   
9-KPA + + - - - - -   1 
10-KPA + + - - - - -   1 
11-KPA + + + - - - - 1   
12-KPA + + + + - - - 1   
13-KPA + - - - - - -   1 
14-KPA + + + - - - - 1   
15-KPA + + + - - - - 1   
16-KPA + + + + - - - 1   
17-KPA + + + + - - - 1   
18-PDA + - - - - - -   1 
19-PDA + + + + + + - 1   
20-PDA + + + - *   1   
21-PDA + + + - *   1   
22-PDA + + + - *   1   
23-PDA + + + *    1   
24-PDA + + - *      1 
25-PDA + + + - *   1   
26-PDA + + + - *   1   
27-PDA + + + + - *  1   
28-PDA + + + - *   1   
29-PDA + + - *      1 
30-PDA + + + - *   1   
31-PDA + + + - *   1   
32-PDA + + + - *   1   
33-PDA + + + - *   1   
34-PDA + + - - *     1 
35-PDA + - - *      1 
36-PDA + - - - *     1 
37-PDA + + + + - *  1   
38-PDA + - - - *     1 
39-PDA + + - *      1 
40-PDA + - - *      1 
41-PDA + - - *      1 
42-PDA + - - *      1 
43-PDA + + + + *   1   
44-PDA + + + *    1   
45-PDA + + + - *   1   
46-PKH + + + - *   1   
47-PKH + + + *    1   
48-PKH + + + - *   1   
49-PKH + - - *      1 
50-PKH + + + - *   1   
51-PKH + - - *      1 
52-PKH + - - *      1 
53-PKH + - - *      1 
54-PKH + - - *      1 
55-PKH + - - *      1 
56-PKH + - - *      1 
Total        32 2 22 
 
ETF: Early Treatment Failure; LTF: Late Treatment Failure;  ACPR: Adequate Clinical and Parasitological Response; *:  LTFU (Lost to follow up) 
DISCUSSION 
 
The malariometric survey indicated that all selected 
villages have a meso - to high endemic status.  Areas 
with mesoendemic status include coastal Hamadi 
whereas Depapre, Tablasupa I and II, of the Depapre 
sub-district had high endemic status.  In all villages, 
two species of the malaria parasites, P. falciparum 
and P. vivax were found either as a single infection or 
mixed of the two species. This malaria situation, 
although only indicated the point prevalence and 
probably does not really reflect the annual parasite 
incidence in the area,  is relatively similar to that 
reported previously in various sites in Papua.
5,  12 , 13 
 
Based on the age group, nearly half of the malaria 
cases were from the age group of less than 10 year 
old. Of these, 20 subjects had age ranged from 0-4 
years. The mixed infection cases were also mainly 
found in this age group. The findings are in accordance 
with the common phenomenon in many malaria 
endemic regions where the younger age group is most 
vulnerable and also indicated that malaria transmission 
occurred in all selected villages.  Malaria infection in 
infant and young children is generally associated with 
local transmission as they mostly stay at home and 
have not frequently traveled as that the elder age. The 
high proportion of falciparum malaria cases carrying 
gametocytes also indicated a high potential transmission 
in the surveyed area. This phenomenon was also 
recently seen in our study in West Sumba.
14 
   
 
The malariometric survey also revealed that the majority 
of the 185 malaria positive subjects exhibited no 
symptom and sign for malaria and microscopic 
analyses showed that 82.7% of the total cases had a 
low parasite density. The findings indicated that the 
majority of the subjects may have acquired naturally 
immunity to enable them develop malaria without or 
subtle clinical manifestation and that are most likely 
to have long been exposed to malaria. Previous 
studies that follow non-immune Javanese migrants to 
Papua indicated that susceptibility to parasitemia and 
fever in adults showed an age dependent diminution 
after 2 years and this phenomenon is parallel to the 
lifelong resident in the area.
15
 
 
The high treatment failure rate with the antimalarial 
drug, sulfadoxine-pyrimethamine, in the area indicated 
an alarming situation for the use of this drug.  
Sulfadoxine-pyrimethamine have been more widely 
used in the last few years in Indonesia following the 
spread of chloroquine resistance.
16
 Although its use 
should consider certain condition such as allergy to 
sulpha drugs, the formulation of this drug is  preferred 
as it is simple and being given in a single dose, and 
therefore very much fit to the condition in Papua and 
frontier sites in Indonesia where access to the health 
facilities are very much limited. The 60.7% failure 
rate that was found in this study is a three-fold increase 
to that results reported previously.
17 
This significant 
increase in treatment failure was probably associated 
with the massive use of this drug following the failure 
of chloroquine to treat most malaria cases in this area. 
In support of the findings, molecular analyses of 
various blood samples from the area indicated that the P. 
falciparum isolates collected from this areas have indeed 
carried the drug-resistant alleles for both chloroquine 
and sulphadoxine-pyrimethamine.
5,16
 In this regard, to 
fill the lack of suitable antimalarial treatment regiment in 
this area, a new antimalarial drug combination such as 
artemisinin-based combination therapy (ACT) is 
highly recommended to be deployed. 
 
In conclusion, our malariometric survey and antimalarial 
drug test using sulphadoxine-pyrimethamine in Jayapura 
District revealed a high malaria point prevalence in 
the area as well as a high treatment failure rate with 
the drug. These results alert to the need of deploying 
new antimalarial regiment that suit the remote setting 
where the malaria diagnosis and treatment were 
mainly based on clinical symptom and without proper 
monitoring.   
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